Duterte extends community quarantine in NCR, C. Luzon, Calabarzon, other ‘high-risk’ areas until May 15
The WHO told the Financial Times that the draft is undergoing peer review and was published early in error.A spokesman for Gilead told AFP: “We believe the post included inappropriate characterizations of the study,” saying it was terminated early due to low enrollment and was therefore not statistically meaningful.
Remdesivir, which is administered intravenously, was among the first drugs suggested as a treatment for the novel coronavirus and as such has great hopes riding on it.Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine, who was not involved in the research, said “the trial was too small in numbers recruited” to detect either benefit or risk.
The US National Institutes for Health also reported it had proven effective in a small experiment on monkeys.
Inquirer, did you forget to journalism?
Ah, but rumors abound that China is sabotaging the drug because they failed to steal the patent...
At this point, I do not trust any study coming out of China.